← Research library

Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices.

Lab research · 2004

What was studied
Rat hippocampal slices
Main finding
Pyroglutamyl-asparagine amide facilitated weakly induced long-term potentiation and countered ethanol-impaired potentiation in rat hippocampal slices. This separate piracetam-inspired dipeptide is not CPG.

Study data at a glance

Participants or experimental model
Rat hippocampal slices
Reported results
Pyroglutamyl-asparagine amide facilitated weakly induced long-term potentiation and countered ethanol-impaired potentiation in rat hippocampal slices. This separate piracetam-inspired dipeptide is not CPG.
Study limitations and source details

Study limitations

  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

In vitroEnglish abstract

Kapai NA, Chepkova AN, Gudasheva TA, Morozova AA, Skrebitskii VG. Pyroglutamyl-asparagine amide normalizes long-term potentiation in rat hippocampal slices. Bulletin of experimental biology and medicine

Study source ↗ · DOI 10.1023/b:bebm.0000048374.18525.2e · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards